Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
An update from Clover Corporation Limited ( (AU:CLV) ) is now available.
Clover Corporation Limited announced a change in the director’s interest, with Fiona Pearse acquiring 62,996 ordinary shares through an on-market purchase, increasing her total holdings to 149,028 shares. This transaction, valued at $40,050, reflects a strategic move by the director, potentially indicating confidence in the company’s future performance and stability, which could positively impact stakeholder perceptions.
The most recent analyst rating on (AU:CLV) stock is a Buy with a A$0.50 price target. To see the full list of analyst forecasts on Clover Corporation Limited stock, see the AU:CLV Stock Forecast page.
More about Clover Corporation Limited
Clover Corporation Limited operates in the health and nutrition industry, focusing on the development and commercialization of innovative ingredients and products. The company is known for its specialty in microencapsulation technology, which enhances the stability and delivery of sensitive ingredients, particularly in the infant formula and nutritional supplement markets.
Average Trading Volume: 153,887
Technical Sentiment Signal: Hold
Current Market Cap: A$108.5M
Find detailed analytics on CLV stock on TipRanks’ Stock Analysis page.